Mealey's (July 21, 2022, 8:12 AM EDT) -- BOSTON — Drug manufacturer Biogen Inc. has agreed in principle to pay $900 million to settle a whistleblower’s lawsuit that it paid kickbacks to health care professionals to prescribe the company’s multiple sclerosis (MS) drugs, according to separate July 20 statements by the relator and the company....